Underwriting AgreementUnderwriting Agreement • September 21st, 2022 • Clearmind Medicine Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 21st, 2022 Company Industry Jurisdiction
Cooperation AgreementCooperation Agreement • September 21st, 2022 • Clearmind Medicine Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 21st, 2022 Company IndustryThis Cooperation Agreement (“Agreement”) is entered into as of March 7, 2022 (“Effective Date”) between Scisparc Ltd. with an office at 20 Raoul Wallenberg St. Building A, 2nd Fl. (“Scisparc”) and ClearMind Medicine Inc. with offices at 101 – 1220 W 6 Ave Vancouver, BC V6H 2R8, on behalf of itself and its affiliates (“CM”). Each shall be referred hereinafter as “Party” and together – as “Parties”.
FORM OF INDEMNITY AGREEMENTForm of Indemnity Agreement • September 21st, 2022 • Clearmind Medicine Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledSeptember 21st, 2022 Company Industry JurisdictionNOW THEREFORE, in consideration of the premises and the covenants and agreements herein contained, the parties agree as follows:
ContractClearmind Medicine Inc. • September 21st, 2022 • Pharmaceutical preparations • New York
Company FiledSeptember 21st, 2022 Industry JurisdictionTHE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING [●], 2022 (THE “EFFECTIVE DATE”) TO ANYONE OTHER THAN (I) AEGIS CAPITAL CORP. OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING FOR WHICH THIS PURCHASE WARRANT WAS ISSUED TO THE UNDERWRITER AS CONSIDERATION (THE “OFFERING”), OR (II) A BONA FIDE OFFICER OR PARTNER OF AEGIS CAPITAL CORP.
AMENDMENT TO THE SUBSCRIPTION AGREEMENTThe Subscription Agreement • September 21st, 2022 • Clearmind Medicine Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 21st, 2022 Company IndustryTHIS AMENDMENT (the “Amendment”) to the Subscription Agreement dated February 3, 2022 (the “Agreement”) is made on June 29, 2022, by and between Clearmind Medicine Inc. (the “Corporation”) and Medigus Ltd. (the “Investor”, and together with the Corporation, the “Parties”).